12/11/2024
3:32 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
1:51 PM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:38 PM | Kiromic BioPharma (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
09/30/2024
3:29 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
5:44 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
2:04 PM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024
7:01 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/28/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:21 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:32 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:30 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:35 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:36 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:36 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:37 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:00 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/20/2024
5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/10/2024
9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:29 PM | Kiromic BioPharma (Issuer)
Mirandola Leonardo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
4:00 PM | BERSANI PIETRO (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024
5:17 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024
4:00 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024
4:58 PM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:55 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:57 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:56 PM | Kiromic BioPharma (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
01/11/2024
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
9:25 AM | Empery Asset Management, LP (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13G/A | |
